Condition
AIDS and Infections
Total Trials
5
Recruiting
1
Active
1
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
Termination Rate
0.0%
0 terminated out of 5 trials
Late-Stage Pipeline
20%
1 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
4Total
Not Applicable (2)
P 1 (1)
P 3 (1)
Trial Status
Unknown3
Withdrawn1
Recruiting1
Clinical Trials (5)
Showing 5 of 5 trials
NCT05814432Phase 3Recruiting
Efficacy and Safety of High-dose Liposomal Amphotericin B for Disseminated Histoplasmosis in AIDS
NCT05510973Not ApplicableUnknown
Evaluation of Advanced HIV Disease Differentiated Care Model in Malawi
NCT05473325Unknown
Benchtop NMR Spectroscopy for Assessment of Clinical Human Pathologies (BRANCH-P STUDY)
NCT05299645Not ApplicableUnknownPrimary
The BeT Study Intervention to Reduce Disparities in HIV Prevention and Care
NCT04144335Phase 1Withdrawn
N-803 Combined With the Broadly Neutralizing Antibodies Plus or Minus haNK Cells for HIV
Showing all 5 trials